Foad Rommasi
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
-
- Advanced Drug Delivery Systems
Papers in
-
- COVID-19 Clinical Research Studies 2
-
- Ubiquitin and proteasome pathways 1
- RNA Interference and Gene Delivery 1
- Co-authors
- Neda Esfandiari (1 shared paper)Mohammad Javad Nasiri (5 shared papers)Mehdi Mirsaeidi (2 shared papers)Neda Soleimani (1 shared paper)Hossein Ramezani (1 shared paper)Bahareh Hajikhani (2 shared papers)
- Journals
- Nanoscale Research Letters (1 paper)Microbial Pathogenesis (1 paper)Molecular and Cellular Biochemistry (1 paper)Scientific Reports (1 paper)Open Life Sciences (1 paper)
- Partner nations
- IranUnited States
In The Last Decade
Foad Rommasi
8 papers receiving 272 citations
Peers
Comparison fields: 5 of 78
- Biomaterials 93
- Pharmaceutical Science 25
- Biotechnology 26
- Biomedical Engineering 85
- Molecular Medicine 9
Countries citing papers authored by Foad Rommasi
This map shows the geographic impact of Foad Rommasi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Foad Rommasi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Foad Rommasi more than expected).
Fields of papers citing papers by Foad Rommasi
This network shows the impact of papers produced by Foad Rommasi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Foad Rommasi. The network helps show where Foad Rommasi may publish in the future.
Co-authors
The 6 scholars most cited alongside Foad Rommasi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 191 | |
| 2 | 2021 | 34 | |
| 3 | 2022 | 19 | |
| 4 | 2022 | 9 | |
| 5 | 2021 | 9 | |
| 6 | 2022 | 7 | |
| 7 | 2023 | 5 | |
| 8 | 2022 | 3 | |
| 9 | 2022 | 0 |
About Foad Rommasi
Foad Rommasi is a scholar working on Infectious Diseases, Molecular Biology, Biomedical Engineering, Surgery and Neurology, having authored 9 papers that have together received 277 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (2 papers), Nanoplatforms for cancer theranostics (2 papers), Ubiquitin and proteasome pathways (1 paper), Pharmacological Effects of Natural Compounds (1 paper), Medicinal Plant Research (1 paper), Heparin-Induced Thrombocytopenia and Thrombosis (1 paper), Nanoparticle-Based Drug Delivery (1 paper) and RNA Interference and Gene Delivery (1 paper). The work is most often cited by research in Biomaterials (93 citations), Pharmaceutical Science (25 citations), Biotechnology (26 citations), Biomedical Engineering (85 citations) and Molecular Medicine (9 citations). Foad Rommasi has collaborated with scholars based in Iran and United States. Frequent co-authors include Neda Esfandiari, Mohammad Javad Nasiri, Mehdi Mirsaeidi, Neda Soleimani, Hossein Ramezani and Bahareh Hajikhani. Their work appears in journals such as Nanoscale Research Letters, Microbial Pathogenesis, Molecular and Cellular Biochemistry, Scientific Reports and Open Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.